AU8185491A - Treatment of disease - Google Patents

Treatment of disease

Info

Publication number
AU8185491A
AU8185491A AU81854/91A AU8185491A AU8185491A AU 8185491 A AU8185491 A AU 8185491A AU 81854/91 A AU81854/91 A AU 81854/91A AU 8185491 A AU8185491 A AU 8185491A AU 8185491 A AU8185491 A AU 8185491A
Authority
AU
Australia
Prior art keywords
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81854/91A
Inventor
Blaik Phillip Halling
James Warren Winkelman
Debra Ann Witkowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
FMC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FMC Corp filed Critical FMC Corp
Publication of AU8185491A publication Critical patent/AU8185491A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
AU81854/91A 1990-06-11 1991-06-10 Treatment of disease Abandoned AU8185491A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53579490A 1990-06-11 1990-06-11
US535794 1990-06-11

Publications (1)

Publication Number Publication Date
AU8185491A true AU8185491A (en) 1992-01-07

Family

ID=24135791

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81854/91A Abandoned AU8185491A (en) 1990-06-11 1991-06-10 Treatment of disease

Country Status (7)

Country Link
AU (1) AU8185491A (en)
CS (1) CS176291A3 (en)
IE (1) IE911971A1 (en)
IL (1) IL98405A0 (en)
PT (1) PT97937A (en)
WO (1) WO1991019418A1 (en)
ZA (1) ZA914435B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US6084155A (en) 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
WO1997032011A1 (en) * 1996-02-28 1997-09-04 Novartis Ag Dna molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
CN103694243B (en) * 2013-12-20 2015-09-09 中国农业大学 2-substituted pyridinyl-1,2,4-triazolo [1,2-a] pyridazine compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3175083D1 (en) * 1980-12-18 1986-09-11 Wellcome Found Pharmaceutical compounds, their preparation and use
CA1192545A (en) * 1982-02-16 1985-08-27 Glaxo Group Limited Heterocyclic derivatives as histamine h.sub.2- antagonists
US5025029A (en) * 1986-10-10 1991-06-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin
US4820722A (en) * 1987-08-14 1989-04-11 Eli Lilly And Company Disubstituted tetrazoles and their use as leukotriene antagonists
US4847276A (en) * 1988-09-06 1989-07-11 Merrell Dow Pharmaceuticals Inc. Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione

Also Published As

Publication number Publication date
PT97937A (en) 1992-04-30
CS176291A3 (en) 1992-08-12
IE911971A1 (en) 1991-12-18
WO1991019418A1 (en) 1991-12-26
ZA914435B (en) 1992-03-25
IL98405A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
AU674894B2 (en) Treatment of conditions and disease
AU639192B2 (en) Treatment of water
AU4048295A (en) Peptide medicaments for the treatment of disease
AU8910891A (en) Treatment of lung diseases
AU6068290A (en) Invalid walker
AU7428291A (en) Treatment of fabrics
AU7428491A (en) Treatment of fabrics
AU5216690A (en) Periodontal disease treatment system
AU6660090A (en) Treatment of depression
AU1279788A (en) Compounds and treatment
AU8185491A (en) Treatment of disease
AU5340594A (en) Skin treatment
AU7428391A (en) Treatment of fabrics
AU8879691A (en) Treatment of dispersions
AU1931895A (en) Treatment of graft-versus-host disease
AU1593792A (en) Treatment of mastitis
AU6863191A (en) Treatment of protozoal diseases
AU7695891A (en) Treatment of autoimmune diseases
AU1604692A (en) Treatment of longitudinally extending members
AU8819691A (en) Treatment of gas
GB9216360D0 (en) Treatment of blood
AU7323091A (en) Treatment of wastewater
AU2823392A (en) Treatment of nephritis
AU654973B2 (en) Prevention of plant disease
GB8829366D0 (en) Treatment of disease